Activity, structure, and diversity of Type II proline-rich antimicrobial peptides from insects
Apidaecin 1b (Api), the first characterized Type II Proline-rich antimicrobial peptide (PrAMP), is encoded in the honey bee genome. It inhibits bacterial growth by binding in the nascent peptide exit tunnel of the ribosome after the release of the completed protein and trapping the release factors. By genome mining, we have identified 71 PrAMPs encoded in insect genomes as pre-pro-polyproteins. Having chemically synthesized and tested the activity of 26 peptides, we demonstrate that despite significant sequence variation in the N-terminal sequence, the majority of the PrAMPs that retain the conserved C-terminal sequence of Api are able to trap the ribosome at the stop codons and induce stop codon readthrough-all hallmarks of Type II PrAMP mode of action. Some of the characterized PrAMPs exhibit superior antibacterial activity in comparison with Api. The newly solved crystallographic structures of the ribosome complexed with Api and with the more active peptide Fva1 from the stingless bee demonstrate the universal placement of the PrAMPs' C-terminal pharmacophore in the post-release ribosome despite variations in their N-terminal sequence.
Authors
- Gemma C. Atkinson (ORCID: https://orcid.org/0000-0002-4861-4584)
- Alexander S. Mankin (ORCID: https://orcid.org/0000-0002-3301-827X)
- Yury S. Polikanov (ORCID: https://orcid.org/0000-0002-5064-0327)
- Nora Vázquez‐Laslop (ORCID: https://orcid.org/0000-0003-2256-693X)
- Elena V. Aleksandrova (ORCID: https://orcid.org/0000-0002-1808-5319)
- Chetana Baliga (ORCID: https://orcid.org/0000-0001-9876-6810)
- Weiping Huang (ORCID: https://orcid.org/0000-0002-7306-3550)
Institutions
- Lund University (SE)
- M S Ramaiah University of Applied Sciences (IN)
- University of Illinois Chicago (US)
- University of Chicago (US)
Publication Details
- Journal
- EMBO Reports
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1038/s44319-024-00277-5
- Citations
- 14
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 4.83
Funders
- National Science Foundation
- U.S. Department of Defense
- U.S. Department of Energy
- Vetenskapsrådet
- National Institutes of Health
- Office of Science
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- Biological and Environmental Research
- Office of Research Infrastructure Programs, National Institutes of Health
- Argonne National Laboratory
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases